samedan logo
 
 
spacer
home > pmps > summer 2018 > adopting automation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Adopting Automation

For decades, robotics have been available, but have been either too costly or difficult to implement. With significant improvements to software and machine-learning, along with more cost-effective robot manufacturing, robotics have become a viable option for players throughout the supply chain, including small-scale operations.

Robotics have never been as adaptable as they are today, and this will increase exponentially in the near future. This flexibility, in conjunction with radical improvements in software, will fuel an explosion in robotics implementation.

Robotic Opportunities

Automation offers a wealth of opportunities in the pharma industry. Recent advances in automation technology have made it more accessible and userfriendly. Upgrading or creating manufacturing lines with more automation increases reliability, safety, compliance, security, and, in most cases, efficiency. These benefits have made automation more than a show piece for highvalue lines, but a major component in modern manufacturing.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
John McCullough, Continuous Improvement Engineer at Sharp Services, leads the US department’s lean development and transformation. His background has been focussed on lean transformations over the past 10 years in industries such as pharma, chemical, and consumer products. John has experience in operations management, continuous improvement/operational excellence, industrial engineering, material requirements planning systems, and quality management. He has a master’s degree in industrial engineering from Lehigh University, US, and an undergraduate in mathematics and physics from Moravian College, US. 

Justin Ludwig, Operations Project Manager at Sharp Services, designs and implements novel mechanical and electrical solutions to improve packaging processes and equipment. 
spacer
John McCullough
spacer
spacer
spacer
Justin Ludwig
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

"Genome Editing of Immune Cells" - New Lonza Virtual Event

Basel, Switzerland, 06 September 2022 – On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions and a concluding panel discussion. The event is a chance for researchers to engage directly with leading voices in the field, keep up to date with the latest CRISPR research and application, and discover tips and tricks for optimized CRISPR editing and screening.
More info >>

White Papers

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Pharm-Olam, LLC

Over the past decade, biopharmaceutical companies have increasingly turned to emerging markets as a way to reduce clinical trial costs and timelines. Areas such as Eastern Europe, India, and Latin America—with their ready population of treatment naïve patients—can be an answer to the intense competition for patients seen in developed markets. Many of the countries within these regions may now be considered as “emerged” countries but yet, conducting trials in these regions does require some special attention and expertise. Before deciding to conduct studies in these areas, companies should have a full appreciation for the ethical, medical, regulatory, legal, and operational hurdles that must be surmounted for success. Here we highlight a number of those issues and offer our recommendations for how sponsor companies can deal with them effectively.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement